Microbiologics Inc recalls
8 notices naming Microbiologics Inc as the recalling firm, since February 19, 2025. A notice covers specific products and lots, not every product of the firm.
Hazard and remedy text is quoted from the agency, unedited. The tag names the kind of risk with a word from that text. Every notice links to its official page.
Microbiologics Inc: KWIK-STIK 2-Pack and 2 more
Hazard (FDA): Affected units may fail to recover the target microorganism Campylobacter jejuni subsp. jejuni derived from ATCC 29428.
FDAMedical devices
Microbiologics Inc: KWIK-STIK
Hazard (FDA): Some products packaged for lot 818-111-7 may have been packaged in pouches labeled as lot 857-53-10.
FDAMedical devices
Microbiologics Inc: LYFO-DISK and 1 more
Hazard (FDA): KWIK-STIK REF numbers: 0894P, 0894K and LYFO DISK" 0894L may result in failure to recover the target microorganism. All lots of REF 894-76 are impacted.
FDAMedical devices
Microbiologics Inc: KWIK-STIK and LYFO DISK
Hazard (FDA): Affected products contain Staphylococcus epidermidis instead of the expected Brevundimonas diminuta. This may cause the user's quality control to fail and delayed diagnosis for the patient.
FDAMedical devices
Microbiologics Inc: KWIK-STICK
Hazard (FDA): Affected products were packaged with the incorrect KWIK STIK assembly resulting in the product containing the wrong microorganism. 0621K was packaged 01065K swabs; 01065K was packaged with 0621K swabs. This may lead to…
FDAMedical devices
Microbiologics Inc: Helix Elite Inactivated Standard: Inactivated Influenza A/B and Respiratory Syncytial…
Hazard (FDA): The RSV target may give a late Ct value and could potentially not pass QC.
FDAMedical devices
Microbiologics Inc: Helix Elite" Inactivated Standard: Inactivated SARS-CoV-2 Whole Virus
Hazard (FDA): The A549 human cell target (human cells for sample adequacy control) may give a late Ct value.
FDAMedical devices
Microbiologics Inc: Microbiologics Multi-Strain Human Papillomavirus and 1 more
Hazard (FDA): Internal quality control procedures were not followed correctly for the testing/release of three lots of 8234/8235. This resulted in the release of products that should have failed and been discarded. The concentration…
FDAMedical devices